Martha E. Gadd

503 total citations
20 papers, 417 citations indexed

About

Martha E. Gadd is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Martha E. Gadd has authored 20 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Oncology and 3 papers in Genetics. Recurrent topics in Martha E. Gadd's work include CAR-T cell therapy research (11 papers), Mitochondrial Function and Pathology (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Martha E. Gadd is often cited by papers focused on CAR-T cell therapy research (11 papers), Mitochondrial Function and Pathology (4 papers) and Viral Infectious Diseases and Gene Expression in Insects (4 papers). Martha E. Gadd collaborates with scholars based in United States, Canada and Saudi Arabia. Martha E. Gadd's co-authors include Douglas R. Pfeiffer, Elliott D. Crouser, Rodney L. Biltonen, Kimberly M. Broekemeier, M Julián, Gustav Graff, Jitendra Kumar, Richard Burack, John Anthony Bauer and Mark D. Wewers and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Martha E. Gadd

19 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha E. Gadd United States 10 268 49 46 40 40 20 417
Noriaki Arakawa Japan 16 304 1.1× 59 1.2× 34 0.7× 93 2.3× 35 0.9× 36 614
Jason Wong Canada 10 275 1.0× 44 0.9× 37 0.8× 53 1.3× 16 0.4× 13 448
Masahiko Ueno Japan 10 234 0.9× 44 0.9× 26 0.6× 42 1.1× 63 1.6× 11 583
Shan Duan China 9 211 0.8× 31 0.6× 63 1.4× 20 0.5× 36 0.9× 42 416
Amy L. Wiseman United States 7 261 1.0× 25 0.5× 33 0.7× 66 1.6× 34 0.8× 7 578
Siobhan E. Moriarty-Craige United States 7 327 1.2× 32 0.7× 23 0.5× 59 1.5× 13 0.3× 7 618
Zhongyong Jiang China 15 233 0.9× 28 0.6× 100 2.2× 27 0.7× 30 0.8× 30 546
Nina Zolotarjova United States 12 572 2.1× 62 1.3× 38 0.8× 53 1.3× 30 0.8× 21 862
Elena Valeria Fuior Romania 13 323 1.2× 59 1.2× 29 0.6× 66 1.6× 34 0.8× 20 573
Blanca Delgado‐Coello Mexico 13 239 0.9× 40 0.8× 38 0.8× 55 1.4× 25 0.6× 36 553

Countries citing papers authored by Martha E. Gadd

Since Specialization
Citations

This map shows the geographic impact of Martha E. Gadd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha E. Gadd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha E. Gadd more than expected).

Fields of papers citing papers by Martha E. Gadd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha E. Gadd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha E. Gadd. The network helps show where Martha E. Gadd may publish in the future.

Co-authorship network of co-authors of Martha E. Gadd

This figure shows the co-authorship network connecting the top 25 collaborators of Martha E. Gadd. A scholar is included among the top collaborators of Martha E. Gadd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha E. Gadd. Martha E. Gadd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Luo, Yan, Martha E. Gadd, Yaqing Qie, et al.. (2024). Solid cancer-directed CAR T cell therapy that attacks both tumor and immunosuppressive cells via targeting PD-L1. SHILAP Revista de lepidopterología. 32(4). 200891–200891. 4 indexed citations
3.
Jarmi, Tambi, Yan Luo, Yaqing Qie, et al.. (2024). CAR T-cell therapy—paving the way for sensitized kidney transplant patients. Kidney International. 105(5). 1124–1129. 6 indexed citations
4.
Qie, Yaqing, Martha E. Gadd, Qing Shao, et al.. (2024). Targeting chronic lymphocytic leukemia with B‐cell activating factor receptor CAR T cells. SHILAP Revista de lepidopterología. 5(9). e716–e716. 1 indexed citations
5.
Mohty, Razan, Martha E. Gadd, Yan Luo, et al.. (2023). Chimeric Antigen Receptor T-cell Therapy for Chronic Lymphocytic Leukemia: What is the supporting evidence so far?. PubMed. 5(4). 33–46. 2 indexed citations
6.
Luo, Yan, Yaqing Qie, Martha E. Gadd, et al.. (2023). Translational development of BAFF-R-specific chimeric antigen receptor T-cell therapy targeting B-cell lymphoid malignancies.. Journal of Clinical Oncology. 41(16_suppl). e19501–e19501. 1 indexed citations
7.
Luo, Yan, Yaqing Qie, Martha E. Gadd, et al.. (2023). Translational development of a novel BAFF-R CAR-T therapy targeting B-cell lymphoid malignancies. Cancer Immunology Immunotherapy. 72(12). 4031–4047. 13 indexed citations
8.
Badar, Talha, Alak Manna, Martha E. Gadd, Mohamed A. Kharfan‐Dabaja, & Hong Qin. (2022). Prospect of CAR T-cell therapy in acute myeloid leukemia. Expert Opinion on Investigational Drugs. 31(2). 211–220. 9 indexed citations
9.
Mohty, Razan, Martha E. Gadd, Yan Luo, et al.. (2022). CAR-T cell Therapies for B-cell Lymphoid Malignancies. Hematology/Oncology and Stem Cell Therapy. 15(3). 81–93. 7 indexed citations
10.
Luo, Yan, et al.. (2022). Abstract 2855: Antitumor activity of BAFF-R targeting CAR T-cells on chronic lymphocytic leukemia. Cancer Research. 82(12_Supplement). 2855–2855. 2 indexed citations
11.
Kharfan‐Dabaja, Mohamed A., et al.. (2021). Driving Out Chronic Lymphocytic Leukemia With CAR T Cells. Transplantation and Cellular Therapy. 28(1). 5–17. 7 indexed citations
12.
Chastain, James E., Mark Sanders, Michael A. Curtis, et al.. (2015). Distribution of topical ocular nepafenac and its active metabolite amfenac to the posterior segment of the eye. Experimental Eye Research. 145. 58–67. 36 indexed citations
13.
Kumar, Jitendra, et al.. (2009). Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress. Archives of Biochemistry and Biophysics. 490(1). 1–8. 22 indexed citations
14.
Gadd, Martha E., Kimberly M. Broekemeier, Elliott D. Crouser, et al.. (2006). Mitochondrial iPLA2 Activity Modulates the Release of Cytochrome c from Mitochondria and Influences the Permeability Transition. Journal of Biological Chemistry. 281(11). 6931–6939. 76 indexed citations
15.
Crouser, Elliott D., M Julián, Mandar Joshi, et al.. (2004). Abnormal permeability of inner and outer mitochondrial membranes contributes independently to mitochondrial dysfunction in the liver during acute endotoxemia*. Critical Care Medicine. 32(2). 478–488. 70 indexed citations
16.
Crouser, Elliott D., et al.. (2003). Quantitation of cytochrome c release from rat liver mitochondria. Analytical Biochemistry. 317(1). 67–75. 72 indexed citations
17.
Chidiac, Peter, Martha E. Gadd, & John R. Hepler. (2002). Measuring RGS Protein Interactions with Gqα. Methods in enzymology on CD-ROM/Methods in enzymology. 344. 686–702. 11 indexed citations
18.
Gadd, Martha E., et al.. (2001). Changes in Ca2+ Affinity upon Activation of Agkistrodon piscivorus piscivorus Phospholipase A2. Biochemistry. 40(11). 3264–3272. 8 indexed citations
19.
Gadd, Martha E. & Rodney L. Biltonen. (2000). Characterization of the Interaction of Phospholipase A2 with Phosphatidylcholine−Phosphatidylglycerol Mixed Lipids. Biochemistry. 39(32). 9623–9631. 30 indexed citations
20.
Burack, Richard, Martha E. Gadd, & Rodney L. Biltonen. (1995). Modulation of Phospholipase A2: Identification of an Inactive Membrane-Bound State. Biochemistry. 34(45). 14819–14828. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noriaki Arakawa Breakdown of academic impact, for papers by Jason Wong Breakdown of academic impact, for papers by Masahiko Ueno Breakdown of academic impact, for papers by Shan Duan Breakdown of academic impact, for papers by Amy L. Wiseman Breakdown of academic impact, for papers by Siobhan E. Moriarty-Craige Breakdown of academic impact, for papers by Zhongyong Jiang Breakdown of academic impact, for papers by Nina Zolotarjova Breakdown of academic impact, for papers by Elena Valeria Fuior Breakdown of academic impact, for papers by Blanca Delgado‐Coello
Rankless by CCL
2026